The document provides an overview of four major psychedelic drugs: PCP, MDMA, ketamines, and nitrous oxide. It discusses their history, effects, and current legal status. Two of the drugs, PCP and ketamines, are NMDA receptor antagonists that produce dissociative effects. The document also covers the discovery and use of MDMA in psychotherapy before it was scheduled and banned for recreational use.